• Delayed Hemolytic Transfusion Reaction Can Lead to Poor Outcome in SCD
  • Novartis Announces Funding for Projects Aimed at Supporting Sickle Cell Disease Community
  • New Tool Helps Primary Care Physicians Provide Better Care for SCD Patients, Study Shows
  • School Staff Lacks Knowledge about Sickle Cell Disease, Student Survey Finds
  • Phase 1 Trial to Test Under-the-Skin Injection of Sevuparin in Sickle Cell Patients
  • Virtual Reality Program May Provide Effective Relief From Pain for SCD Patients, Study Suggests
  • #NORDSummit – Major Issues on Table for Rare Disease Patients in US as Midterm Elections Approach
  • Emmaus-sponsored ASCAT Conference Outlines Latest Sickle Cell Advances
  • HemoType SC is a Fast, Inexpensive Diagnostic Tool for Sickle Cell Disease Screening, Study Shows
  • Marijuana Use Common in Sickle Cell Patients, Highlighting Need for More Research, Study Shows
  • Crizanlizumab Lowers Pain Crises in At-risk Sickle Cell Patients, Ad-hoc Trial Data Show
  • Multi-Organization Partnership to Encourage Blood Donation and SCD Awareness